rs3780378

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004972.4(JAK2):​c.3060-10716C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.501 in 257,364 control chromosomes in the GnomAD database, including 33,071 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 19811 hom., cov: 33)
Exomes 𝑓: 0.49 ( 13260 hom. )

Consequence

JAK2
NM_004972.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.215

Publications

19 publications found
Variant links:
Genes affected
JAK2 (HGNC:6192): (Janus kinase 2) This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]
INSL6 (HGNC:6089): (insulin like 6) The protein encoded by this gene contains a classical signature of the insulin superfamily and is significantly similar to relaxin and relaxin-like factor. This gene is preferentially expressed in testis. Its expression in testis is restricted to interstitial cells surrounding seminiferous tubules, which suggests a role in sperm development and fertilization. [provided by RefSeq, Jul 2008]
TCF3P1 (HGNC:49742): (transcription factor 3 pseudogene 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.519 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004972.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK2
NM_004972.4
MANE Select
c.3060-10716C>T
intron
N/ANP_004963.1O60674
JAK2
NM_001322194.2
c.3060-10716C>T
intron
N/ANP_001309123.1O60674
JAK2
NM_001322195.2
c.3060-10716C>T
intron
N/ANP_001309124.1O60674

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK2
ENST00000381652.4
TSL:1 MANE Select
c.3060-10716C>T
intron
N/AENSP00000371067.4O60674
JAK2
ENST00000870320.1
c.3060-10716C>T
intron
N/AENSP00000540379.1
JAK2
ENST00000870321.1
c.3060-10716C>T
intron
N/AENSP00000540380.1

Frequencies

GnomAD3 genomes
AF:
0.508
AC:
77170
AN:
151896
Hom.:
19800
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.482
Gnomad AMI
AF:
0.589
Gnomad AMR
AF:
0.508
Gnomad ASJ
AF:
0.586
Gnomad EAS
AF:
0.520
Gnomad SAS
AF:
0.536
Gnomad FIN
AF:
0.600
Gnomad MID
AF:
0.513
Gnomad NFE
AF:
0.501
Gnomad OTH
AF:
0.509
GnomAD4 exome
AF:
0.491
AC:
51770
AN:
105350
Hom.:
13260
Cov.:
0
AF XY:
0.496
AC XY:
28510
AN XY:
57486
show subpopulations
African (AFR)
AF:
0.451
AC:
860
AN:
1908
American (AMR)
AF:
0.460
AC:
1965
AN:
4272
Ashkenazi Jewish (ASJ)
AF:
0.558
AC:
1296
AN:
2324
East Asian (EAS)
AF:
0.468
AC:
1723
AN:
3678
South Asian (SAS)
AF:
0.504
AC:
9126
AN:
18092
European-Finnish (FIN)
AF:
0.573
AC:
3404
AN:
5944
Middle Eastern (MID)
AF:
0.522
AC:
242
AN:
464
European-Non Finnish (NFE)
AF:
0.481
AC:
30172
AN:
62694
Other (OTH)
AF:
0.499
AC:
2982
AN:
5974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1176
2353
3529
4706
5882
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.508
AC:
77212
AN:
152014
Hom.:
19811
Cov.:
33
AF XY:
0.513
AC XY:
38141
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.482
AC:
19983
AN:
41450
American (AMR)
AF:
0.508
AC:
7763
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.586
AC:
2033
AN:
3468
East Asian (EAS)
AF:
0.520
AC:
2667
AN:
5128
South Asian (SAS)
AF:
0.536
AC:
2588
AN:
4826
European-Finnish (FIN)
AF:
0.600
AC:
6353
AN:
10588
Middle Eastern (MID)
AF:
0.483
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
0.501
AC:
34074
AN:
67950
Other (OTH)
AF:
0.508
AC:
1073
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2014
4027
6041
8054
10068
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
682
1364
2046
2728
3410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.515
Hom.:
2590
Bravo
AF:
0.498
Asia WGS
AF:
0.532
AC:
1848
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
7.9
DANN
Benign
0.84
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3780378; hg19: chr9-5112288; API